This review demonstrates enhanced acne treatment outcomes with combined acids in acne vulgaris, suggesting optimized formulations may improve management.
Acne vulgaris is a multifactorial inflammatory skin disorder driven by abnormal keratinization, microbial proliferation, excessive sebum production, and immune-mediated inflammation. Acidic compounds such as salicylic acid (SA), azelaic acid (AZA), and lactic acid (LA) have gained attention for their keratolytic, antimicrobial, and anti-inflammatory effects. However, monotherapies face limitations such as poor penetration, irritation, and limited efficacy. A combined approach using SA, AZA, and LA may enhance therapeutic outcomes by leveraging their complementary actions: SA’s follicular penetration and comedolytic effect, AZA’s antimicrobial and anti-inflammatory properties, and LA’s keratin modulation and hydration benefits. This review examines their synergistic potential, mechanisms, and clinical relevance, highlighting the need for optimized formulations and clinical validation to improve acne management.
No takes yet. Share an insight, caveat, or question.
Shang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: